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ABSTRACT
SLC44A2 (solute carrier 44a2), also known as CTL2
(choline transporter-like protein 2), is expressed in many
supporting cell types in the cochlea and is implicated in
hair cell survival and antibody-induced hearing loss. In
mice with the mixed C57BL/6-129 background, homo-
zygous deletion of Slc44a2 exons 3–10 (Slc44a2Δ/Δ)
resulted in high-frequency hearing loss and hair cell
death. To reduce effects associated with age-related
hearing loss (ARHL) in these strains, mice carrying the
Slc44a2Δ allele were backcrossed to the ARHL-resistant
FVB/NJ strain and evaluated after backcross seven
(N7) (99 % FVB). Slc44a2Δ/Δ mice produced abnor-
mally spliced Slc44a2 transcripts that contain a frame-
shift and premature stop codons. Neither full-length
SLC44A2 nor a putative truncated protein could be
detected in Slc44a2Δ/Δ mice, suggesting a likely null
allele. Auditory brain stem responses (ABRs) of mice
carrying the Slc44a2Δ allele on an FVB/NJ genetic
background were tested longitudinally between the
ages of 2 and 10 months. By 6 months of age,
Slc44a2Δ/Δ mice exhibited hearing loss at 32 kHz,
but at 12 and 24 kHz had sound thresholds similar to
those of wild-type Slc44a2+/+ and heterozygous +/
Slc44a2Δ mice. After 6 months of age, Slc44a2Δ/Δ
mutants exhibited progressive hearing loss at all
frequencies and +/Slc44a2Δ mice exhibited moderate
threshold elevations at high frequency. Histologic
evaluation of Slc44a2Δ/Δ mice revealed extensive hair
cell and spiral ganglion cell loss, especially in the basal
turn of the cochlea. We conclude that Slc44a2
function is required for long-term hair cell survival
and maintenance of hearing.
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INTRODUCTION
SLC44A2 (solute carrier 44a2) is a transmembrane
glycoprotein (Nair et al. 2004) that belongs to the
solute carrier family of osmolyte transporters involved
in transmembrane transport of small molecules
(He et al. 2009). It is highly expressed in inner ear
supporting cells and was discovered as the target of a
monoclonal antibody, KHRI-3 (Zajic et al. 1991).
In vivo administration of KHRI-3 resulted in hearing
loss in mice and guinea pigs, thereby implicating this
protein in antibody-mediated hearing loss (Nair et al.
1995, 1997, 1999). SLC44A2 is also strongly expressed
in supporting cells in the human inner ear and is
involved in autoimmune hearing loss in humans
(Disher et al. 1997; Zeitoun et al. 2005; Kommareddi
et al. 2009). Since antibody to SLC44A2 adversely
affects hair cell survival and hearing, we postulated
that this protein must be essential for normal function
of the inner ear. To study its role in hearing, we
created targeted knockout mice that carried a dele-
tion of exons 3–10 of the Slc44a2 gene. Initial studies
of the effects of this deletion on a C57BL/6 genetic
background revealed hair cell loss and hearing loss,
but were hampered by the age-related hearing loss
(ARHL) associated with the Cdh23753A variant carried
by C57BL/6J (Noben-Trauth et al. 2003). We
backcrossed the Slc44a2 deletion onto the FVB/NJ
strain, which carries the ARHL-resistant Cdh23753G or
wild-type allele. Here, we demonstrate that the Slc44a2
deletion on a majority FVB background results in
early-onset hearing loss, particularly at high frequen-
cy. The hearing loss is progressive and is associated
with extensive hair cell and spiral ganglion cell loss.
Thus, this study indicates a critical role of Slc44a2 in
the maintenance of auditory function.
METHODS
Targeting Vector Construction and Targeted
Disruption of the Slc44a2 Gene in Embryonic
Stem Cells
129/SvJ mouse strain genomic DNA was obtained
from the Jackson Laboratory (Bar Harbor, ME).
Three pairs of primers (Table 1) were used to amplify
the Slc44a2 targeted region (exons 3–10) (Fig. 1A)
and the 5′ and 3′ homology arms on either side of
these exons. The 5′ homologous (5′ HA) arm spans
3.1 kb of the distal end of intron 2; the 1.9-kb targeted
deletion site (TDS) includes exons 3–10; and the 3′
homologous arm (3′ HA) spans the 2.7-kb proximal
region of intron 10. The PCR products were cloned
into pGEM-T vectors, and wild-type sequences were
verified by the University of Michigan DNA
Sequencing Core. Standard molecular cloning tech-
niques were used to insert the Slc44a2 fragments into
the pLoxPFlpNeo vector (Hiraoka et al. 2006). This
vector contains the neomycin resistance gene (PGKneo
cassette) between FRT recombination sites for antibi-
otic selection after transfection of the targeting
construct into mouse embryonic stem (ES) cells. The
final targeting construct contained the TDS between
the loxP recombination sites, the 5′ HA preceding the
5′ FRT site and the 3′ HA following the 3′ loxP site
(Fig. 1B).
The targeting vector was linearized with SacII and
electroporated into R1 agouti mouse ES cells (129X1/
SvJx129S1/SvJ) (Nagy et al. 1993). Electroporation
and antibiotic selection of mouse ES cells were
performed at the University of Michigan Transgenic
Animal Model Core (Hughes and Saunders 2011).
Genomic DNA prepared from neoR ES cell clones was
analyzed for homologous recombination of the
targeting construct by long-range genomic PCR
(Expand Long Kit—Roche, Indianapolis, IN) with
two primer sets (Table 2): GGGGGCAGGGAGGG
CTAAATCT (forward, Hour F (Homologous up-
stream region Forward)) located upstream of the 5′
HA and GCCTACCGGTGGATGTGGAATGTG
(reverse, Hour R) derived from the PGKneo cassette,
and with control primers for the wild-type Slc44a2
gene: GCACCGAAGGAATGGGGAAGGAT (nHourF
(normal HourF)) located upstream of the 5′ HA and
CATCTCGCCAGCCCCAGGTCATAC (PosR-nHourF
(Positive control reverse primer for nHourF)) located
near the distal end of the 5′ HA (Fig. 1B).
Confirmation of Recombinant Clones Using
Southern Blot
A 411-bp hybridization probe (probe 1) was amplified
from genomic DNA sequences located upstream of
the 5′ HA, gel purified, doubly radiolabelled with 32P-
dCTP plus 32P-dATP (Perkin Elmer, Waltham, MA)
using the Prime-Gene Labeling System (Promega,
Madison, WI), and separated from unincorporated
nucleotides by centrifugation through a Sephadex
column. Ten micrograms of genomic DNA from PCR-
positive ES clones was digested overnight with HindIII
in the presence of 4 mM spermidine. Restriction
fragments were separated by electrophoresis on 0.8 %
agarose gels with 1× TBE buffer and transferred to
Zetaprobe GT filters (Bio-Rad Labs, Hercules, CA).
The radiolabeled probe was prehybridized with 50 μg
mouse Cot-1 DNA (Life Technologies, Invitrogen,
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Grand Island, NY) at 65 °C 30 min before adding the
probe to the filters. Hybridization with the
radiolabeled probe was carried out in 0.5 M sodium
phosphate and 7 % SDS, pH 7.2, at 65 °C overnight.
Filters were washed at 65 °C for 15 min twice in the
following solutions containing 0.1 % SDS: 2× SSC, 1×
SSC, 0.2× SSC, and 0.1× SSC. Biomax-MS film (Kodak)
was exposed to filters with an intensifying screen at
−80 °C for 2 days (Meisler et al. 2013).
Sequencing of ES Cell Clone 29, Subcloning,
Selection, and Blastocyst Injection and
Implantation
DNA was isolated from 1500 neoR colonies of
electroporated ES cells and examined for proper
insertion of the construct. PCR analysis determined
a single clone (clone 29) was positive for correct
homologous recombination. The construct from pos-
itive clone 29 was completely sequenced to ensure an
intact insertion. The full set of sequencing primers is
given in Table 2. Clone 29 was found to be heteroge-
neous and was subcloned; 50 subclones were
rescreened by genotyping (primers in Table 3). PCR-
positive subclones with normal karyotypes were select-
ed for blastocyst injection and implantation in pseu-
dopregnant mice. Male progeny (ES cell-mouse
chimeras) were selected based on high coat color
contribution and genotyping results and were bred to
wild-type C57BL/6 mice to generate N1 offspring. N1
germ line founders carrying the Slc44a2neo allele
(B6;129Sv-Slc44a2tm1Tec) were crossed with pCAGGs-
FLP mice (Kranz et al. 2010). The resulting N2
Slc44a2flox mice (B6;129Sv-Slc44a2tm1.1Tec) were then
crossed with B6.FVB-Tg(EIIa-Cre) mice carrying a Cre
recombinase gene on the adenovirus EIIa promoter
(Cat Number 003724) (Jackson Labs, Bar Harbor,
ME) to delete Slc44a2 exons 3–10 and generate the
mutant Slc44a2Δ allele (B6;129Sv-Slc44a2tm1.2Tec).
DNA/RNA Extraction, Genotyping, RT-PCR, and
Sequencing
To obtain genomic DNA, mouse tail tip biopsies were
each digested overnight at 55 °C in 1 ml of tail
solubilization buffer (TSB) (Miller et al. 1988) con-
taining 45 μl (927 AU) proteinase K (Qiagen,
Valencia, CA; cat 19131) activated at 37 °C. TSB as
modified here consisted of 100 mM Tris-HCl pH 8.5,
5 mM EDTA, 0.2 % SDS, and 200 mM NaCl. After
digestion, the samples were cooled and 400 μl of
chilled tail salts (4.21 M NaCl, 0.63 M KCl, and 10 mM
Tris (pH 8.0)) was added to precipitate the proteins
and SDS. The samples were vigorously mixed and
incubated for 1 h at 4 °C. Insoluble material was
removed by centrifugation and genomic DNA was
precipitated from the supernatant by the addition of
two volumes of cold 100 % ethanol, and centrifuga-
tion. After washing the pellet, the extracted DNA was
dissolved in 150 μl TE buffer (Invitrogen, Grand
Island, NY) and then PCR-genotyped. Both Expand
Long Template PCR and GC Rich kits (Roche
Diagnostics, Indianapolis, IN) were used with Hour
primers (Table 2). Genotyping primers used to assess
deletion of the neo-cassette and the exons 3–10 are
listed in Table 3. Cochlea (one to two ears), lung, and
kidney tissues (~30 mg) were homogenized using a
1.5-ml disposable pellet/pestle tube or a polytron
homogenizer, and RNA was isolated using RNeasy
mini kit or a Trizol/chloroform method (Qiagen,
Valencia, CA). Reverse transcription PCR (RT-PCR)
was performed (Kommareddi et al. 2010), and
complementary DNA (cDNA) was prepared from total
RNA isolated from homozygous knockout FVB (lung)
and C57BL/6 (kidney) tissues; these were analyzed for
Slc44a2 expression and submitted for Sanger sequenc-
ing using the primers shown in Table 4.
Backcrossing to the FVB Strain
B6;129Sv-+/Slc44a2Δ mice carrying the targeted allele
were backcrossed to FVB/NJ mice for seven genera-
t ions (N7) to generate a line (FVB.129Sv-
Slc44a2tm1.2Tec) with 99 % FVB genetic background
on average. Intercrosses were carried out at N7 to
assess hearing loss in F1 wild-type (+/+), heterozygous
(+/Slc44a2Δ), and homozygous mutant (Slc44a2Δ/Δ)
progeny. Heterozygous progeny mice were
intercrossed to maintain the strain. Representative
mice from this N7-F1 group were used for immuno-
histochemistry and morphometric analysis, auditory
brain stem response (ABR) testing, spiral ganglion cell
counts, and necropsy.
TABLE 1
Primers used for cloning the targeting region
5′ KO F TTCCTTGCTCTGCTTTGTAAGTCC 5′ KO R CTGTTCATTTTGAAAACTTT- 3.1 kb
Ex KO F AGACCAGACCTGGTGGCACAG Ex KO R GGTAGCAGACATTTGGCACTT 1.9 kb
3′ KO F CCGGGACCGCTTTCAGAA 3′ KO R GACATTAGGTAAACATCTTCA 2.7 kb
5′ KO F and 5′ KO R amplify the 5′ homologous region; Ex-KO F and Ex KO R amplify the exon 3–10 targeted deletion site; and 3′ KO F and 3′ KO R amplify the 3′
homologous region
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Immunohistochemistry and Morphometric
Analysis
Cochleae from FVB N7-F1 +/+, +/Slc44a2Δ, and
Slc44a2Δ/Δ mutant mice were processed for whole-
mount immunohistochemistry and morphometric
analysis. Immunohistochemistry was done using anti-
myosin 7A (hair cells) and rhodamine phalloidin
(actin) using published protocols (Sha et al. 2008).
Expression of Slc44a2 in the transgenic mice was
carried out using affinity-purified rabbit anti-CTL2-NT
as described previously (Beyer et al. 2011). Inner ear
cross sections were generated in the KHRI Core
Histology Facility and evaluated. Photographs were
taken using both light and confocal microscopy. Hair
cell counts were completed from surface preparations
as described (Sha et al. 2008). The cytocochleogram-
obtained data was compared to a database of normal
CBA/J mouse cochlea, and missing hair cell percent-
ages were calculated for each row and plotted as a
function of the distance from the apical to the basal
end of the surface preparation.
Auditory Brain Stem Response Testing and
Analysis
ABR testing (Sha et al. 2008) was carried out at 12, 24,
and 32 kHz at different time points. Mixed models
were generated to examine differences in hearing
thresholds among the three genotype groups while
accounting for age, frequency, and repeated measures
on the same mice. Comparisons focused on relating
FVB N7-F1 +/Slc44a2Δ and Slc44a2Δ/Δ mice to +/+
mice. Kaplan-Meier curves were also produced to
demonstrate the time to development of threshold
950 dB sound pressure level (SPL) by genotype. A 50-
dB SPL was selected since it represents the start of
moderate hearing loss. Statistical significance was
defined as pG0.05. Mixed model and Kaplan-Meier
analyses were performed using Stata 13.1 (StataCorp,
2013 StataCorp, College Station, TX).
Spiral Ganglion Cell Counts and Analysis
Counts of spiral ganglion cell (SGC) bodies in apical,
middle, and basal turns from FVB N7-F1 mice were
performed using published methodology (Sha et al.
2008). Raw counts and spiral ganglion cell density
(cells/10,000 μm2) were determined and then ana-
lyzed. A generalized linear model (GLM) examined
the role of cochlear location (apex, middle, base)
and genotype (i.e., +/+, +/Slc44a2Δ, Slc44a2Δ/Δ) as a
correlate of SGC density. Statistical significance was
defined as pG0.05. The Tukey-Kramer method was
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FIG. 1. A The predicted topology of the SLC44A2 isoform P2
protein. Each ball represents an individual amino acid. The region
targeted for deletion in the knockout is shown in green. The amino
acids colored red are included in the first 29 amino acids encoded by
a truncated and aberrantly spliced Slc44a2 mRNA produced in the
knockout mouse. Small arrows at E3 and E11 point to the sites where
the aberrant transcript is spliced, leading to an out-of-frame transcript
that is terminated by two stop codons in exon 14. Open triangles
indicate locations of predicted N-linked glycosylation sites. R/Q
indicates the codon 152 (isoform P1)/154 (isoform P2) arginine/
glutamine polymorphism. B Experimental design of the Slc44a2
gene-knockout mouse. Exons 3–10 of the mouse Slc44a2 gene were
chosen for deletion. The targeting construct was created with a 5′
homology region followed by a neo-cassette flanked by FRT sites,
loxP sites flanking exons 3–10, and finally, the 3′ homology region.
Mice carrying the targeting construct in the correct location were
mated with FLP recombinase-expressing mice to remove the neo-
cassette, and their offspring were mated to Cre recombinase-
expressing mice to delete Slc44a2 exons 3–10.
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isons. GLM and post hoc comparisons were per-
formed using SAS 9.4 (SAS Institute, 2014, Cary, NC).
Full Phenotype Analysis (Necropsy)
FVB N7-F1 mice were analyzed for whole-body histo-
pathology in the Unit for Laboratory Animal
Medicine, Pathology Service. Animals were eutha-
nized humanely using CO2, and euthanasia was
confirmed with thoracotomy. Full necropsies were
performed on animals in the Unit for Laboratory
Medicine Pathology sections by MH. This evaluation
included complete blood counts and assessments of
brain, heart, lung, liver, kidney, spleen, mesenteric
lymph node, thymus, eye, skin, skeletal muscle,
stomach, duodenum, jejunum, ileum, colon, rectum,
and reproductive tract, which were collected in 10 %
neutral buffered formalin (NBF) for routine histopa-
thology examination. The tympanic bullae were
opened with a 22-gauge needle and placed in 10 %
NBF for 48 h. The heads were then sectioned at the
posterior aspect of the eyes to remove the rostral
portion of the skull, and sectioned along the midline.
The soft tissue around the tympanic bullae was
dissected away, and specimens were placed in
Immunocal (Decal Corporation, Tallman, NY) for
24 h for decalcification. Specimens were embedded
in paraffin and sectioned routinely for histopathology.
Immunoprecipitation and Western Blot
CTL2-NT antibody raised in rabbits immunized with an
SCL44A2 unique but phylogenetically conserved anti-
genic peptide encoded by exon 2 in the N-terminal
portion of SLC44A2 was used for immunoprecipitation
and Western blot analysis of SLC44A2 in lung and
kidney extracts prepared as described previously (Nair
et al. 2004; Kommareddi et al. 2009, 2010).
RESULTS
Generation of a Targeted Deletion of Slc44a2
The Slc44a2/Ctl2 gene has 22 exons encoding 706
amino acids. Exons 3–10 encode the first and largest
extracellular loop of the protein (Nair et al. 2004)
shown in green in Figure 1A. The KHRI-3 antibody
that induces hearing loss in mice and guinea pigs
(Nair et al. 1995, 1997) targets an N-linked carbohy-
drate moiety of the SLC44A2 protein (Kommareddi
et al. 2010). Two of the consensus N-linked glycosyl-
ation sites (shown as open triangles, Fig. 1A) are
located on the first outer loop (Nair et al. 2004;
Kommareddi et al. 2010). Based on the logic that this
large protein loop is important to the normal function
of the protein, exons 3–10 were chosen for deletion in
ES cells using a targeting vector (Fig. 1B). Correct
targeting in ES cell clones was verified by PCR and
Southern blot analysis. One ES cell clone, number 29,
was targeted correctly. This clone was subcloned and
TABLE 2
Sequencing the rCTL2 insert from clone 29 (E29/plate)
Hour F GGGGGCAGGGAGGGCTAAATCT Hour R GCCTACCGGTGGATGTGGAATGTG
nHour F GCACCGAAGGAATGGGGAAGGAT PosR-nHourF CATCTCGCCAGCCCCAGGTCATAC
5′ HO F CCCAAAGATCCAAAACAGTCCACA 5′ HO R GCCCGGGCTACATTGAGAGTC
5′ HO F1 TTTATGTCTGTGGTCTGCGTTGTG 5′ HO R1 CAGCCAAACCTTATCTCCAGTCCT
Lox P scrn F GGCAGGACAGCAAGGGGGAGGAT Lox P scrn R ACGGGGCTCTGGGTCTCAAAGTT
Ex KO F GGGCGAATTCTGTGGGCAAAAG Ex KO R AGGGGAAGAGGTGAAACGCATTAC
3′ KO F CCGGGACCGCTTTCAGAA 3′ KO R GACATTAGGTAAACATCTTCA
3′ HO R GCCGGGGCTACATTGAGAAACT 3′ HO R1 GTAGAGCCGCAAACGCAGACAGTA
3′ KO-3′ HO F1 GCAGGTCGAGGGACCTAATAAC 3′ KO-3′ HO R1 GGTGTTAGCAGGCCTGGAGAAATG
3′ HO F2 TCAGTTCCAGCTTTCAGTTTCCTT 3′ HO R2 AGCCACAACCATAGCACCTCACTG
3′ HO F3 GGTCTGCCCCCTTCGTTTTACA 3′ HO R3 ACGGGGCTCTGGGTCTCAAAGTT
3′ HO F4 GGCCGTCTGAGCTTGATGTCTGTC 3′ HO R4 AATTATGCACAGGAGGCTTAGTCA
3′ HO F7 CCTGGCTTTTCTGTATTCTGATGC
3′ HO F GGCGACTTGATATTTGTTTTTGAT
3′ HO F5 CCTGGATGGCTTTTAGTGAGTTGC
TABLE 3
Primers used for genotyping
Primer name Sequence
NeoGenoF2 TGA TGC TCT TCG TCC AGA TCA TCC
NeoGeno R1 TGA ACA AGA TGG ATT GCA CGC AGG
NeoDelFn2 GGACTCGGTGCCCTTCTGGA
NeoDelRn2 TGGCTGGCCTAAAACCTGCTATG
Exon D F1 GGGGATGCGGTGGGCTCTAT
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progeny clones were PCR tested for the 3.3-kb
recombined insert containing the neo-cassette
(Figs. 1B and 2A). Incorrectly targeted clones showed
no 3.3-kb band (clone 78) and wild-type cells (+/+)
had only the 3.1-kb band. The murine Slc44a2 gene
has two HindIII sites, one upstream of the 5′
homologous region and the other in the 3′ homolo-
gous region, which span 8.4 kb in length in the wild-
type mouse. After recombination, a new HindIII site
in the vector located after the 5′ FRT site (Fig. 1B) was
expected to produce a 6.0-kb 5′ fragment in HindIII-
digested DNA of correctly targeted clones. Southern
blot analysis demonstrated that this 6.0-kb fragment
(as well as the wild-type 8.4-kb fragment) was recog-
nized by the probe in five PCR-positive subclones
(Fig. 2B).
The five correctly targeted ES subclones (Fig. 2A,
B) were sequenced and verified to contain the
complete Slc44a2 recombinant gene. Three clones
exhibiting normal karyotypes were injected into
blastocysts and implanted in pseudopregnant female
mice. ES cell-mouse chimeras were bred to C57BL/6
mice. Germ line transmission of the transgene from
all three clones was detected in genomic DNA of
resulting N1 offspring using primer sets that amplify
across the neo-cassette and exons 3–10. Transgene-
positive mice were crossed with C57BL/6 mice
carrying FLP recombinase (Kranz et al. 2010),
resulting in progeny mice (NeoΔSlc44a2flox) with suc-
cessful removal of the neo-cassette (Fig. 3A, B). Neo-
deleted Slc44a2flox/+ mice were intercrossed to obtain
progeny that were +/+, +/Slc44a2flox, and Slc44a2flox/
Slc44a2flox (Fig. 3C, D). Homozygous Slc44a2flox/
Slc44a2flox mice were crossed with C57BL/6 mice
carrying Cre recombinase to produce the mutant
Slc44a2Δ allele with deletion of exons 3–10. The +/
Slc44a2Δ mice were then crossed and the progeny
TABLE 4
Primers used for Slc44a2 full-length cDNA sequencing of wild-type and knockout mice
Mouse-specific full-length primers for isoforms P1 and P2
MsP1 CTL2/SLC44A2 F TCGCGCTGGCTTCGGACTCA
MsP1 CTL2/SLC44A2 R GCACAGGGCTGGGCATA CAAG
MsP2 CTL2/SLC44A2 F GCGGGTGGCGGCTGTGTC
MsP2 CTL2/SLC44A2 R GGATGGCCAAAGTAGGGGTGAGG
Sequencing primers
Forward primers Location and name
1. ATGGGACGCCTCAGAAATACGA Ms AK041533 90–111 bp MsCTL2F1
2. ACACTCGCGACTTTGACTATTACA Ms AK041533 438–461 bp MsCTL2F2
3. GCGATTCCTGGCTGGCATTAT Ms AK041533 814–834 bp MsCTL2F3
4. CCCCTTGCGGAATGAGAGC Ms AK041533 1294–1312 bp MsCTL2F4
5. GGTACCACACGGGCTCCTTAG Ms AK041533 1551–1571 bp MsCTL2F5
6. ATTGTGGGTAGTGTGGGCATCC Ms AK041533 1880–1901 bp MsCTL2F6
Reverse primers Location and name
1. AGAAGCTTGCTGCAGACATCCTA Ms AK041533 2472–2494 bp MsCTL2R1
2. GTCAGGATCGGAACCCAGTAATAA Ms AK041533 1963–1986 bp MsCTL2R2
3. GCCCGTGTGGTACCTGAGTGCT AK041533 1543–1564 bp MsCTL2R3
4. CCCTGCTGGCTTCTTTGATG Ms AK041533 1093–1112 bp MsCTL2R4
5. AAAGGTTTGCTGGGGGTGATA Ms AK041533 538–558 bp MsCTL2R5
6. CAGGGGGTTGGCACACTTCA Ms AK041533 278–297 bp MsCTL2R5
DNA











FIG. 2. PCR and Southern blot results for five positive ES cell
subclones. A PCR genotyping of DNA from the five positive ES cell
subclones carrying the Slc44a2 targeting construct (3.3-kb PCR
product), subclone 78 that lacked the targeting construct, and +/+
(wild-type) mouse DNA (3.1-kb PCR product) without the construct.
B Southern blot showing the presence of the Slc44a2 8.4-kb wild-
type and the 6.0-kb recombinant construct in the five positive
subclones of clone 29.
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were found to have the expected distribution of +/+,
+/Slc44a2Δ, and Slc44a2Δ/Δ genotypes (Fig. 3E, F).
Mutant Slc44a2Δ/Δ Mice on the C57BL/6 Back-
ground
Slc44a2Δ/Δ mice appeared healthy and fertile and did
not exhibit circling or head tilting behavior. No visible
size difference or other atypical observations were
noted upon necropsy between normal and knockout
mice except for changes in the inner ear described
below. RT-PCR of RNA from lung and kidney tissue of
+/+, +/Slc44a2Δ, and Slc44a2Δ/Δ mice (C57BL/6
background) was conducted to detect the expression
of Slc44a2 isoforms P1 and P2 (P1, using the upstream
exon 1a, and P2, using the more proximal exon 1b)
(Kommareddi et al. 2010). Full-length transcripts
(3.3 kb) of both isoforms were expressed in +/+ mice.
Both isoforms of the 3.3-kb full-length transcripts and
both isoforms of the deleted 2.5-kb Slc44A2Δ tran-
script (lacking exons 3–10) were expressed in the +/
Slc44a2Δ animals. As expected in Slc44a2Δ/Δ mutants,
only the 2.5-kb Slc44A2Δ transcripts of the P1 and P2
isoforms were observed (Fig. 4A). Similarly, after
transfer of the deleted allele to the FVB strain
(Fig. 4B), the wild-type 3.3-kb transcript was produced
in +/+ mice, but only the deleted 2.5-kb transcript
could be amplified in cDNA from the lung and
cochlea of the +/Slc44a2Δ and Slc44a2Δ/Δ mice
(Fig. 4B).
Immunoprecipitation of the Slc44a2 protein from
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FIG. 3. Deletion schema in transgenic mice showing the primer
sets and PCR results used to demonstrate successful deletion of the
neo-cassette and Slc44a2 exons 3–10. A, B PCR results for
heterozygous +/neo-deleted floxed Slc44a2, +/Neo-Slc44A2, and a
wild-type animal +/+ without the construct. C, D PCR results for
correct location of floxed exons 3–10 in heterozygous +/Slc44a2flox
and homozygous Slc44a2flox/Slc44a2flox, as well as +/+ mice. E, F
PCR results for homozygous Slc44a2Δ/Slc44a2Δ, heterozygous +/
Slc44a2Δ, and +/+ mice after crossing to C57BL/6 carrying Cre.
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Slc44a2Δ/Δ mice was performed using a rabbit
SLC44A2-NT antiserum. (This antiserum, formerly
called CTL2-NT, for the N-terminal CTL2 domain,
was raised to the peptide encoded by exon 2
(Nair et al. 2004; Kommareddi et al. 2009).) The
immunoprecipitated proteins were separated by gel
electrophoresis and Western blot analysis was per-
formed using the SLC44A2-NT antiserum. The full-
length SLC44A2 protein was prominent in lung and
to a lesser extent in kidney tissue from +/+ mice.
Heterozygous +/Slc44a2Δ mice and heterozygous
mice carrying the recombinant +/SLC44A2flox allele
(neo-deleted but exons 3–10 intact) exhibited re-
duced protein expression in lung and undetectable
protein in kidney. Since the kidney expresses much
lower levels of SLC44A2 than lung (Kommareddi
et al. 2010), the absence of one allele apparently was
sufficient to reduce expression in kidney to below
detectable levels. No protein was expressed in the
Slc44a2Δ/Δ mutants (Fig. 4C). Similar results were
observed in protein extracts from the cochlea of FVB
mice after the transfer of the deleted allele to this
strain (Fig. 4C, right panel). Note that the wild-type
protein band in cochlear extracts of the FVB +/
Slc44a2Δ mice is expressed. The RT-PCR failed to
detect the wild-type cDNA in the heterozygous mice
(Fig. 4B) due to relatively low transcript expression
and PCR competition by the shorter deleted tran-
script.
Sequencing of the 2.5-kb transcript Slc44a2Δ/Δ
mice revealed splicing from exon 2 into exon 11
(Fig. 5A, B). The open reading frame of this mutant
transcript matched the wild-type Slc44a2 transcript
from exon 1 through exon 2 including the first amino
acid encoded by exon 3. However, a single nucleotide
frameshift within exon 11 resulted in an alternative
reading frame that lacked similarity to Slc44a2 or any
known protein (Fig. 5B). The reading frame was
terminated by a stop codon within exon 14. The
putative truncated protein, if stable, is predicted to be
150 amino acids in length (17 kDa), with the first 29
amino acids identical to intact Slc44a2 (red text,
Fig. 5B). Multiple attempts to detect the predicted
truncated protein on 12 % gels to insure visualization
of low-mw proteins failed to detect the fusion protein
in either Slc44a2Δ/Δ or +/Slc44a2Δ mice (data not
shown), indicating that the fusion protein is either not
made or is unstable.
FIG. 4. Expression of Slc44a2 message and protein in wild-type
and knockout mice. A RT-PCR using lung and kidney mRNA in the
C57BL/6 strain. The figure demonstrates expression of the mRNA for
both the P1 and P2 Slc44a2 isoforms. Wild-type mouse 1043 and
990 (left and right panels) expressed the full-length 3.3-kb cDNA;
heterozygous mouse 1046 (+/Slc44a2Δ) (center panels) expressed
both the full-length 3.3-kb and the truncated 2.5-kb message; and
homozygous knockout mouse 895 (Slc44a2Δ/Δ) (right panels)
expressed only the truncated 2.5-kb message. In lung, the P2 isoform
is more abundant than P1; however, in kidney, they are equally
expressed. B RT-PCR showing expression of the Slc44a2 P2 isoform
in lung and cochlea in WT, +/+, HET, +/Slc44a2Δ, and KO Slc44a2Δ/
Δ FVB mice. In FVB mice, the overall expression of the Slc44a2
message is less strong than that in the C57 strain. In FVB
heterozygous mice lung and cochlea, the full-length wild-type
message was not detected due to competition by the shorter deleted
transcript. To make the PCR product in FVB cochlear extract more
visible, the photograph of the gel was reversed to black on white. C
Immunoprecipitation and Western blot results using rabbit anti-
SLC44A2-NT. Slc44a2 expression is shown in lung and kidney
samples of C57BL/6 +/+, +/Slc44a2flox, +/Slc44a2Δ, and Slc44a2Δ/Δ
littermates with different genotypes. Mice 1042 and 1043 (+/+)
strongly express Slc44a2 in lung (L) and to a lesser extent in kidney
(K) and have normal hearing. Slc44a2 is expressed in the lung of
heterozygous mouse 1100 carrying one wild-type allele and one
recombinant allele (+/Slc44a2flox, exons 3–10 not yet deleted), but
expression is below the limit of detection in kidney tissue. Mouse
1100 has normal hearing. Heterozygous mouse 944 (+/Slc44a2Δ,
neo; exons 3–10 deleted) has low expression of Slc44a2 in lung and
below detectable levels in kidney. This mouse has hearing loss at
high frequency—65-dB SPL threshold at 48 kHz. Homozygous
knockout mice 895 and 1072 (Slc44a2Δ/Δ) have no Slc44a2
expression in lung or kidney. Mouse 895 has 50- and 70-dB SPL
thresholds at 24 and 48 kHz. Mouse 1072 had a 65-dB SPL threshold
at 48 kHz. Repeated tests using 12 % gels to detect the 150-amino
acid SLC44A2Δ/Δ fusion protein encoded by the alternate transcript
showed no expression of the 17-kDa protein (not shown). Analysis of
protein extracts of cochlea from FVB mice from all three genotypes
show the same results as in C57BL/6 mice with protein expression in
wild-type and heterozygous mice but not in knockout mouse (right
panel). Note that the protein is expressed in the +/Slc44a2Δ mice
even though the message was competed for by the deleted message
in the RT-PCR shown in Figure 4B.
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FIG. 5. A Structure of the deleted Slc44a2 gene. The open reading
frame of this mutant transcript matched the wild-type Slc44a2
transcript through exon 2 and the first amino acid of exon 3, but
exhibited a frameshift in exon 11 that encoded alternative residues
until a stop codon within exon 14. B Putative 150-amino acid
truncated protein deduced from the RT-PCR expressed message. The
first 29 amino acids shown in red are identical to the sequence
encoded by exons 1–2 and the first amino acid of exon 3. The open
reading frame is spliced into exon 11 out-of-frame resulting in an
alternate transcript (in black) that fails to match to any known
proteins. If the protein was produced and stable, it would have a
molecular mass of 17 kDa. As the N-terminal amino acids are
conserved in the fusion transcript, immunoprecipitation and detec-
tion with the N-terminal antibody should detect the fusion protein if
it is produced and stable.
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Mutant Slc44a2Δ/Δ Mice Exhibit High-
Frequency Hearing Loss, Loss of Hair Cells,
and Spiral Ganglion Degeneration
At 3 months of age, ABR analysis of Slc44a2Δ/Δ mice
on the C57BL/6J genetic background revealed poor
hearing thresholds of 65–90 dB SPL at 48 kHz and
50–70 dB SPL at 24 kHz associated with outer hair cell
losses in the basal turns of the cochlea (data not
shown). In contrast, the +/+ and +/Slc44a2Δ mice
exhibited thresholds of 20–30 dB SPL at these
frequencies and relatively low levels of hair cell loss
in the basal turn (data not shown). C57BL/6 mice
carry the Cdh23753A allele at the Ahl locus that is
associated with ARHL (Noben-Trauth et al. 2003).
To avoid the additional effects of this allele on
hearing, we backcrossed Slc44a2Δ mice to the FVB/
NJ strain, which carries the wild-type Cdh23753G allele
associated with lower sound thresholds in later life
(Noben-Trauth et al. 2003). N2 backcross mice
carrying the Slc44a2Δ allele and homozygous for the
FVB Cdh23753G wild-type allele were used as breeders
for subsequent FVB backcrosses leading to the N7
generation. At backcross generation N7 (99 % FVB
genetic background), heterozygous +/Slc44a2Δ mice
were intercrossed to produce F1 wild-type, heterozy-
gous, and knockout animals at the Slc44a2 locus.
Knockout Slc44a2Δ/Δmice in the FVB/NJ background
were generally smaller than their wild-type littermates
but were otherwise healthy and fertile (data not
shown). Anatomic pathology review of systems by
one of us (MH) found no abnormalities of any organ
system (other than the inner ear), including lung and
kidney which strongly express Slc44a2.
Fifty-nine F1 intercross progeny from FVB/NJ
backcross generation N7 (20 +/+, 19 +/Slc44a2Δ, and
20 Slc44a2Δ/Δ) were tested for hearing using ABR
analysis in response to 12, 24, and 32 kHz pure tone
stimuli. In Figure 6A, average hearing thresholds
calculated from repeated measures of the same mice
as they aged from 2 to more than 8 months are shown
for the +/+ and Δ/Δ groups. In Slc44a2Δ/Δ mutants,
hearing loss at 32 kHz developed early and became
notably progressive at all frequencies with age. At all
three frequencies, the hearing thresholds, adjusted
for age, were significantly worse in the Slc44a2Δ/Δ
mutants than in either the +/+ or +/Slc44a2Δ mice
(pG0.0001). Heterozygous +/Slc44a2Δ mice exhibited
progressive hearing loss at 32 kHz from 4 to
98 months of age (not shown). In contrast, +/+
(all frequencies) and +/Slc44a2Δ mice (12 and
24 kHz) exhibited minimal threshold shifts with aging
(≤15 dB). At 24 kHz, changes in threshold after age
adjustment were not significantly different between +/
+ and +/Slc44a2Δ mice (p values 90.3). A full model,
which included all variables, further demonstrated
that ABR results in +/+ and +/Slc44a2Δ mice did not
significantly differ (p values 90.17) after adjustment
for age and frequency. Kaplan-Meier curves demon-
strate time to development of first threshold 950 dB
SPL by genotype (Fig. 6B). We used 50 dB SPL since
this represents moderate hearing loss and there were
not enough mice who reached the 980-dB SPL level to
































FIG. 6. Slc44a2Δ/Δ mice on the FVB background exhibit progres-
sive hearing loss. A Mice carrying the wild-type (WT, +/+) and the
homozygous knockout (KO, Slc44a2Δ/Δ) Slc44a2 alleles on an FVB/
NJ background (N7-F1) were evaluated longitudinally for hearing at
2–4 months of age to 8 or more months. ABRs to pure tone stimuli at
12, 24, and 32 kHz were measured periodically on the mice as they
aged. Each pure tone frequency is indicated by a different shade of
color (12 kHz—light, 24 kHz—medium, 32 kHz—dark). Mean
threshold responses are indicated for WT (blue) and KO (red) mice;
error bars represent standard deviation. N=20 for WT and n=20 for
KO, but some were studied histologically during the course of the
follow-up, resulting in different numbers of mice at the later time
points. At all frequencies, WT mice maintained relatively normal
hearing over time with threshold means between 20 and 25 dB SPL.
Mutant KO mice demonstrated progressive hearing loss at all
frequencies. Slc44a2 loss has the greatest effect at high frequency,
whereas hearing loss was milder at 12 and 24 kHz. B Kaplan-Meier
curve presenting the likelihood of an animal from each genotype
group first developing a hearing threshold above 50 dB SPL
(moderate hearing loss). This curve accounts for all three testing
frequencies (12, 24, and 32 kHz). Each line shows the probability of
mice in each group *not* yet having a threshold greater than 50 dB
SPL. The curves decline over time, as the probability for first
developing a threshold 950 dB SPL increases with age.
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less of testing frequency and demonstrates significant-
ly increased and faster development of hearing loss
with age among the knockout mice compared to the
wild-type and heterozygous groups (p=0.005).
Histologic examination of the inner ear was carried
out on a randomly selected subset of these 59 mice
(N=25) after their final ABR to correlate hearing
status with cochlear morphology. Surface prepara-
tions of the organ of Corti were evaluated for hair cell
survival. Representative images from organ of Corti
surface preparations and cytocochleograms from FVB
N7-F1 +/+, +/Slc44a2Δ, and mutant Slc44a2Δ/Δ mice
are shown in Figure 7, together with the ABR
recordings for these three mice (Fig. 8). By 8 months
of age, the high hearing thresholds observed in
Slc44a2Δ/Δ mutants across all measured frequencies
are associated with relatively high levels of loss of both
inner and outer hair cells throughout the cochlea.
With the exception of the extreme base and apex of
the cochlea, hair cell loss at 8–9 months is relatively
minimal in +/+ and +/Slc44a2Δ mice, which exhibit
lower sound thresholds. The opposite ear of each of
the representative animals was decalcified, fixed, and
sectioned to examine the organ of Corti and the spiral
ganglion in mid-modiolar sections (Fig. 9). The mid-
modiolar sections through the organ of Corti were
consistent with the surface preparation data. The
organ of Corti has a normal appearance in all three
turns of the +/+ mouse. The apex and middle turns of
the mouse exhibited near-normal appearance of the
organ of Corti, but in the basal turn, the outer hair
cells were missing. Visible stereocilia can be seen in
some sections corresponding to both inner and outer
hair cells in the +/+ and +/Slc44a2Δ mice. The
Slc44a2Δ/Δ mouse organ of Corti has a near-normal
appearance in the apex and middle turns, but in the
basal turn, the morphology is abnormal with absence
of the tunnel of Corti and no distinguishable hair cells
(Fig. 9A). These observations bear similarity to the
results in Figure 7. Further examination of the mid-
modiolar sections also revealed gross abnormalities of
the spiral ganglion cells in the basal turn of the +/
Slc44a2Δ mouse and the Δ/Δ mouse. Multiple mid-
modiolar sections from 5 +/+, 4 +/Slc44a2Δ, and 7
Slc44a2Δ/Δ mice were examined for spiral ganglion
cell density as previously described (Sha et al. 2008).
The results are depicted graphically in Figure 10. The
basal segment of the spiral ganglion of the +/Slc44a2Δ
and Slc44a2Δ/Δ animals displayed extensive loss of
cells although severity varied from animal to animal.
In contrast, spiral ganglion cells were intact in the +/+
mice (Fig. 9B). A generalized linear model that
examined both cochlear location (p=0.0026) and
genotype (pG0.0001) revealed that these two are
independently and significantly associated with spiral
ganglion cell density (Table 5). SGC density is
different between the base and middle turns
(p=0.0017); the differences between the base and
apex (p=0.1080) and middle and apex (p=0.2456) are
not statistically significant. When comparing density
across genotypes, there is a statistically significant
difference between +/+ and +/Slc44a2Δ (p=0.0114)
and +/+ and Slc44a2Δ/Δ (pG0.0001). The difference
between heterozygous and knockout mice approaches
significance (p=0.0834) (Table 5).
Inner ear surface preparations from other ++/, +/
Slc44a2Δ, and mutant Slc44a2Δ/Δ mice were also
stained by indirect immunofluorescence with affinity-
purified rabbit anti-Slc44a2 (CTL2-NT) as shown in
Figure 11. Note that the expected expression of
Slc44a2 on supporting cells is present in +/+
(Fig. 11A), less so in +/slc44a2Δ (Fig. 11B, C), and
completely absent from Slc44a2Δ/Δ ears (Fig. 11D),
which is consistent with the Western blots shown in
Figure 4C.
DISCUSSION
A full understanding of the roles of supporting cells in
maintenance of inner ear function is only beginning
(May et al. 2013; Monzack and Cunningham 2013;
Wan et al. 2013). Similarly, the role of the supporting
cell protein SLC44A2 in inner ear function is not well
understood. SLC44A2 was discovered as the antigenic
target of a monoclonal antibody (KHRI-3) raised
against isolated cells from the inner ear (Zajic et al.
1991). KHRI-3 showed strong reactivity with
supporting cells, but not sensory cells, and the
antibody target was called the Bsupporting cell
antigen.^ We demonstrated upregulation of KHRI-3
antigen in areas of hair cell loss induced by drugs or
noise (Ptok et al. 1993). Subsequent studies revealed
that systemic KHRI-3 antibody was capable of causing
hearing loss in mice (Nair et al. 1995). Infusion of
purified KHRI-3 into the guinea pig cochlea led to
antibody binding to supporting cells and loss of
sensory hair cells. Where hair cells were missing,
KHRI-3 antibody staining intensity of adjacent
supporting cells was increased (Nair et al. 1997).
Additionally, potent antigen expression occurred
where adjacent supporting cell membranes form scars
in the space left by the dying hair cell (Nair et al.
1997). These findings strongly suggested that the
KHRI-3-defined supporting cell antigen has important
functions in survival of sensory cells in the cochlea,
and that antibody binding to supporting cells inter-
feres with this function leading to hair cell death.
Additionally, the accumulation of the protein at the
scars implies a role for SLC44A2 in maintaining the
integrity of the reticular lamina of the organ of Corti.






















0 2 4 6















0 2 4 6
















0 2 4 6
















































FIG. 7. Whole-mount surface preparations of the inner ear
from FVB N7 F1 mice at 8 months of age. Left panels: indirect
immunofluorescence (red—phalloidin and green—myosin 7a). Right
panels: cytocochleograms of wild-type mouse 2416 (+/+), heterozy-
gous 2418 (+/Slc44a2Δ), and knockout 2414 (Slc44a2Δ/Δ). Top
panels: +/+ mouse 2416 surface preparation and cytocochleogram
display minimum loss of hair cells from apex to base. Middle panels:
+/Slc44a2Δ mouse 2418 exhibits more frequent outer hair cell loss in
the apex and basal turns, and cytocochleogram displays the same
pattern (depicts a BU^ shaped loss, a typical pattern of age-related
loss/damage). Bottom panels: mouse 2414 (Slc44a2Δ/Δ) demonstrates
extensive hair cell loss in all three turns.
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Immunoprecipitation of the supporting cell anti-
gen from guinea pig inner ear extracts using KHRI-3
yielded protein bands of 68 and 72 kDa. The
peptides from the trypsin-digested bands identified
by tandem mass spectroscopy when compared to
known proteins (Nair et al. 2004) showed homology
to the newly identified CTL1 (choline transporter-
like protein 1) (O’Regan et al. 2000) and identity to
its putative homolog CTL2 (choline transporter-like
protein 2) (Nair et al. 2004). The choline
transporter-like proteins (CTL1–CTL5) were later
classified as members of the superfamily of solute
carrier (SLC) proteins, and CTL2 was designated
SLC44A2. Recombinant CTL1 (SLC44A1) functions
in choline transport in several vertebrate models
(O’Regan et al. 2000; Michel and Bakovic 2012).
SLC44A2 has more homology to SLC44A4 and
SLC44A5 than to SLC44A1 and SLC44A3 (Traiffort
et al. 2013). However, the function of SLC44A2
remains uncertain. Using transduced CHO cells, we
demonstrated only low-level transport of choline by
the SLC44A2-P2 isoform preferentially expressed in
the murine inner ear (Beyer et al. 2011), but not by
the SLC44A2-P1 isoform that is preferentially
expressed in human and guinea pig inner ear
(Kommareddi et al. 2010). However, two groups
have implicated choline transport by SLC44A2/
CTL2 in human cancer cells. Nakamura et al.
observed glucocorticoid-induced expression of
CTL1 and CTL2 messenger RNA (mRNA) and
increased uptake of tritiated choline in the human
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FIG. 8. ABR recordings from the same mice presented in Figure 7.
Top row: mouse 2416 (+/+) exhibits normal hearing at all three
frequencies. Middle row: mouse 2332 (+/Slc44a2Δ) exhibits an
elevated threshold at 32 kHz but normal hearing thresholds at 12
and 24 kHz. Bottom row: mouse 2414 (Slc44a2Δ/Δ) exhibits elevated
thresholds at all three frequencies consistent with the frequent hair
cell loss and spiral ganglion loss as shown in Figure 9.
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CTL1 or CTL2 mRNA specifically decreased CTL1 or
CTL2 expression and choline uptake (Nakamura
et al. 2010). Similarly, knockdown of CTL1, CTL2, or
CTL5 decreased choline transport in H82 small cell
lung cancer cells (Song et al. 2013). Membership of
CTL2/SLC44A2 in the solute carrier protein family
strongly suggests a role in transporting a charged
molecule across the membrane of inner ear
supporting cells. The knockdown experiments also
suggest that these members of the CTL/SLC44
family may work together to form a functional
transporter system, since knockdown of any one of
the three members of the family decreases choline
transport in human cancer cells. This may explain
why expressing SLC44A2 alone was not efficient in
inducing choline transport in CHO cells.
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FIG. 9. Mid-modiolar cochlear plastic sections of the opposite ear
of the same FVB N7 F1 transgenic mice shown in Figure 7. A Top
panels show sections through the organ of Corti of +/+ mouse 2416,
+/Slc44a2Δ mouse 2418, and Slc44a2Δ/Δ mouse 2414. The organ of
Corti appears relatively normal in these sections in +/+ and +/
Slc44a2Δ mice. However, in the Slc44a2Δ/Δ mouse, the organ of
Corti in the base appears abnormal with no detectable tunnel of Corti
and has poor representation of both inner and outer hair cells. B The
lower panels depict the spiral ganglion from the same sections as
shown in the upper panels. Note that in both the +/Slc44a2Δ and
Slc44a2Δ/Δ mice, the spiral ganglion in the basal turn exhibits loss of
numerous cell bodies.
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SLC44A2 is strongly expressed in supporting cells
in the vestibular system (Nair et al. 2004; Beyer et al.
2011) and in the developing mouse otic capsule. In
our developmental study (Beyer et al. 2011), SLC44A2
was expressed in hair cells and supporting cells at
embryonic days E17 and E18, but expression in hair
cells declined and remained only in supporting cells
by postnatal day P1. Therefore, this protein also may
have a role in the early development of the inner ear.
In the current study, we report the effects on
hearing of a targeted deletion of exons 3–10 of
Slc44a2 in the mouse. We opted to delete exons 3–
10 that encode the first and largest outer loop of the
Slc44a2 molecule. The first outer loop has two N-
glycosylation sites that likely contribute to SLC44A2
function, since the KHRI-3 antibody binds to the N-
linked carbohydrate, but not the protein backbone of
SLC44A2 (Nair et al. 2004). Studies of human
antibodies to the human neutrophil antigen HNA3a
carried on the SLC44A2 molecule (Curtis et al. 2010;
Greinacher et al. 2010; Bux 2011) also suggest an
important role for the first outer loop. SLC44A2 is
strongly expressed in lung (Kommareddi et al. 2010)






























FIG. 10. Spiral ganglion cell density (cells/10,000 μm2) across the
apex, middle, and basal turns of the cochlea for 5 +/+, 4 +/Slc44a2Δ,
and 7 Slc44a2Δ/Δ animals. SGCs were intact for +/+ mice at all
regions. The apical and basal parts of the spiral ganglion of Slc44a2Δ/
Δ mice showed extensive loss of cells, while +/ Slc44a2Δ mice
demonstrated density loss only at the base.
TABLE 5
SGC analysis of location/genotype vs. density
Source DF Type III SS Mean square F value Pr9F
Location 2 438.701667 6.87 0.0026 219.350833
Genotype 2 1080.297071 16.91 G0.0001 540.148536
LS means: location vs. density LS means: genotype vs. density
Pr9|t| for H0: LSMean(i)=LSMean(j) Pr9|t| for H0: LSMean(i)=LSMean(j)
i/j Base Mid Apex i/j WT Het KO
Base 0.0017 0.108 WT 0.0114 G0.0001
Mid 0.0017 0.2456 HET 0.0114 0.0834
Apex 0.108 0.2456 KO G0.0001 0.0834
Analysis of the role of cochlear location (apex, middle, base) and genotype (WT [+/+], HET, [+/Slc44a2Δ], KO [Slc44a2Δ/Δ]) as a correlate of spiral ganglion cell
density. Statistical significance defined as pG0.05. When comparing density vs. location, SGC density is only different between the base and middle turns (p=0.0017).
For genotype vs. density, a statistically significant difference was found between WT and HET (p=0.0114) and WT and KO (pG0.0001). The difference in SGC density






FIG. 11. Whole-mount surface preparations of the inner ear from
FVB N7 F4 mice labeled with affinity-purified rabbit anti-SLC44A2
antibody (CTL2-NT) (red). FVB wild-type (+/+) (upper panel) and
heterozygous (+/Slc44a2Δ) (middle panels) exhibit respectively high
and moderate levels of Slc44a2 protein expression in supporting
cells in the organ of Corti; Slc44a2Δ/Δ mice fail to express Slc44a2
(lower panel) in the organ of Corti.
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and on subsets of human white blood cells, notably
granulocytes (Curtis et al. 2010; Greinacher et al.
2010; Bux 2011). The HNA3a/HNA3b neutrophil
antigens are defined by a polymorphism at codon
152 of the SLC44A2 gene that encodes either arginine
or glutamine at this site. HNA3a antibodies arise in
individuals typed as HNA3b and bind to SLC44A2
molecules that express arginine 152. Such antibodies
agglutinate granulocytes and cause degranulation,
indicating a key functional significance of the
SLC44A2 first outer loop. Antibody binding to this
molecule on granulocytes causes degranulation and
release of cytokines resulting in acute lung injury
(Curtis et al. 2011). Antibody binding to lung tissue
itself (Kommareddi et al. 2010) may also contribute to
antibody-mediated lung damage in transfusion-related
lung injury (Bux 2011). Furthermore, KHRI-3 binding
to SLC44A2 interferes with a supporting cell function
that is essential for hair cell survival, since hair cells
begin to die and hearing loss ensues after antibody
binding (Nair et al. 1995, 1997, 1999).
We developed the targeted Slc44a2Δ allele in the
C57BL/6 mouse strain. Slc44a2 transcripts expressed
from the Δ allele spliced out of frame from exon 2 to
exon 11, resulting in a shift of reading frame and a
subsequent premature stop codon. Mice homozygous
for the deletion allele (Slc44a2Δ/Δ) lacked detectable
expression of the full-length SLC44A2 protein. There
was no expression of a truncated protein encoded by
the aberrantly spliced Δ allele, suggesting that this
mutation is likely null. After the Slc44a2Δ allele was
transferred to the FVB/NJ genetic background to
remove the mutant Cdh23753A allele carried by
C57BL/6J, progressive high-frequency hearing loss at
32 kHz developed as early as 4 months in the
homozygous Slc44a2Δ/Δ mice. Progressive hearing loss
also developed in these mice at 12 and 24 kHz after
6 months of age. Hearing loss in the FVB Slc44a2Δ/Δ
mice is accompanied by extensive outer hair cell loss
as well as patchy inner hair cell loss and loss of spiral
ganglion cells in the basal turn were found in both the
Slc44a2Δ/Δ mice and in some +/Slc44a2Δ mice,
suggesting that loss of even one copy of the gene has
adverse effects on inner ear homeostasis.
This study has shown the effects of Slc44a2 deletion
on hearing in a knockout mouse. Further study is
necessary to determine the mechanism underlying
the effects of deletion of Slc44a2 on hair cell survival
and hearing. SLC44A2 is strongly expressed in
supporting cells (Deiter’s cells, pillar cells, inner
border cells, and inner phalangeal cells) directly
adjacent to inner and outer hair cells, both of which
are lost to various degrees in Slc44a2Δ/Δ mutants
(Nair et al. 1997, 1999; Kommareddi et al. 2007).
SLC44A2-enriched supporting cells such as inner
pillar cells, inner border cells, and the third row of
Deiter’s cells are LGR5 positive and can act as
progenitors for hair cells after damage (Shi et al.
2013; Bramhall et al. 2014). The role of SLC44A2 in
supporting cell regeneration (Mellado Lagarde et al.
2014) and supporting cell transdifferentiation into
hair cells (Korrapati et al. 2013; Shi et al. 2013;
Bramhall et al. 2014) is yet to be examined. Antibody
binding to SLC44A2, aminoglycoside treatment, or
noise exposure result in extensive outer hair cell
damage with concomitant upregulation of SLC44A2
expression (Ptok et al. 1993). Scar formation and
sealing of the area of hair cell loss are the natural
processes of the repair of the organ of Corti by
supporting cells (Raphael and Altschuler 1991;
Raphael 2002; Taylor et al. 2012), and our results
suggest involvement of the SLC44A2 protein in this
process (Nair et al. 1999).
We observed progressive hearing loss and SGC loss
in our Slc44a2Δ/Δ mice. We assume that this occurs
due to the ablation of normal protein function in
supporting cells that maintain healthy hair cells and
protect the SGCs. Cunningham’s group showed the
ability of supporting cells to protect hair cells through
upregulation of HSP-70 protein alone (May et al.
2013). Similarly, insulin-like growth factor 1 upregula-
tion in inner ear also protects hair cells through
supporting cell signaling (Yamamoto et al. 2014). Loss
of SGCs in the Slc44a2Δ/Δ mice and in some +/
Slc44a2Δ mice is another consequence of this mutant
gene. Abnormalities of SGC had not been observed in
prior experiments with antibody-induced hearing loss
and hair cell loss (Nair et al. 1995, 1997, 1999); thus,
the abnormal SGC phenotype in the heterozygous
and Scl44a2-knockout mice was new. SLC44A2 ex-
pression can be appreciated in the spiral ganglion
(Kommareddi et al. 2007), but this has not been
extensively evaluated and it is unknown if it has a
direct effect in maintaining SGCs. Genetic deletion of
Slc44a2 and impairment of SLC44A2 function by
antibody binding to N-linked carbohydrate modifica-
tions of the mature protein both lead to damage of
mature sensory cells, which do not express SLC44A2.
Stankovic et al. suggested a neuregulin (NRG1)-
erbB2-erbB3 crosstalk in the inner ear that is essential
for SGC survival. When supporting cell erbB receptor
signaling is lost, SGC neuregulins (NRGs) are also lost
and SGC degeneration occurs (Stankovic et al. 2004;
Monzack and Cunningham 2013). It is conceivable
that loss of SLC44A2 expression in the Slc44a2Δ/Δ
mice could link to changes in erbB receptor and/or
NRG signaling as proposed (Stankovic et al. 2004). In
our previous studies, we have showed that Slc44a2
protein expression is upregulated in damaged hair
cell areas, and in our Slc44a2 knockout study, absence
of this protein results in progressive hearing loss and
SGC loss. It can be concluded that Slc44a2 function in
710 KOMMAREDDI ET AL.: Hearing Loss in the Slc44a2 Knockout Mouse
supporting cells is required for long-term hair cell
survival, spiral ganglion cell survival, and overall
maintenance of hearing.
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